Biogen Defends Newly Approved Alzheimer's Drug

The US Food and Drug Administration has called for a federal investigation of its own regulatory review process after widespread criticism of its decision on Aduhelm.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news